Precision Medicine in Oncology® | Specialty

Dr. Pecora on the Pathway Inhibitor Cabozantinib

May 18th 2011

Dr. Pecora on the Pathway Inhibitor Cabozantinib (XL184)

Jane Armer on Findings From Her Lymphedema Research

May 17th 2011

Jane Armer the director of ALFP on Findings From Her Lymphedema Research

Genomic Test Helps Define Primary Tumor: An Interview With William David Henner, MD, PhD

May 16th 2011

As cancer-fighting therapies become more targeted, clinicians are looking increasingly toward emerging technologies to help confirm the primary site of a patient's disease.

5 Hedgehog Pathway Questions for Michael T. Lewis

May 13th 2011

Michael T. Lewis, PhD, runs a research lab at the Baylor College of Medicine focused on understanding the role of hedgehog signaling in mammary gland development and breast cancer

Ferreting Out the Hedgehog Pathway Emerges as Ripe Target for Cancer Drug Development

May 13th 2011

The Hedgehog gene is an intracellular signaling ligand that initiates the Hh pathway, which is important in the regulation of embryo development from flies to humans

Roswell Park Cancer Institute: A History of Initiative and Innovation

May 12th 2011

Founded in 1898 by Dr Roswell Park, Roswell Park Cancer Institute (RPCI) is the oldest dedicated comprehensive cancer center in the country

Medicine Is in His DNA: Giant in Breast Gene Research Draws on Childhood Values

May 11th 2011

Plenty of children are afraid to go to the doctor. Dennis Slamon used to look forward to it.

Dr. Edith Perez Discusses Her Ongoing Research

April 27th 2011

ASCO Backs EGFR Testing for Lung Cancer Patients

April 15th 2011

The chorus of support is growing among oncology experts for routine genetic testing of tumors from patients with advanced non-small cell lung cancer

Biomarker Test Shows Promise in Diagnoses

April 6th 2011

A biomarker test for DNA methylation identified 22 gene sites able to differentiate between melanoma and nonmelanoma lesions

Federal Spending on Research Into Kidney Cancer Is Rising

April 4th 2011

The use of microRNAs and proteomics-based approaches for early detection are among the foremost research priorities of the National Cancer Institute

Dr. Gomella on Jefferson's Multidisciplinary Cancer Center

March 31st 2011

Landmark Genome Analysis to Drive Multiple Myeloma Research

March 28th 2011

Genome sequencing may help researchers understand the pathogenesis of this cancer, which despite exhaustive research, is only partially understood

Dr. Kris Discusses EGFR Mutation Testing

March 21st 2011

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses EGFR Mutation Testing

Dr. Alter on Trials and Ongoing Research in Kidney Cancer

March 21st 2011

Robert S. Alter, M.D. Co-chief, Urologic Oncology, John Theurer Cancer Center, on major trials and ongoing research in kidney cancer, in the spring of 2011.

Dr. Pearlstone on Ongoing Research in Breast Cancer

March 16th 2011

David Pearlstone, M.D. Co-Division Chief, Breast Oncology from John Theurer Cancer Center, on important research taking place in the field of breast oncology.

Announcing a New Partnership and an Opportunity for Growth

March 16th 2011

The John Theurer Cancer Center is proud to be partnering with Intellisphere to advance this mission by overseeing editorial content development and helping to provide in-depth content, new learning opportunities, and bestpractice approaches to cancer care.

Dr. Pecora on his Personal Involvement in Research

March 15th 2011

Andrew L. Pecora, M.D., F.A.C.P., C.P.E. Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center, on his personal involvement in research.

Dr. Alter Discusses Research at JTCC

March 14th 2011

Dr. Robert Alter on Current Research at John Theurer Cancer Center

Dr. Siegel Discusses the New John Theurer Cancer Center

March 14th 2011

David S. Siegel, MD, PhD, chief, Multiple Myeloma at the John Theurer Cancer Center (JTCC), discusses the new JTCC stand alone cancer center.